↑↓ navigate ↵ open esc close
SELL TO STATE.
Start free trial
Germany TED / Vergabe.de contract award · ocds-ted-222616-2026

Germany – Pharmaceutical products – Bekanntmachung vergebener Aufträge nach §130 c SGB V zu dem Arzneimittel Ublituximab

GWQ ServicePlus AG awarded €1 to neuraxpharm Arzneimittel GmbH for Healthcare & Medical in April 2026 — one of 207 awards this buyer has made, in line with its typical award size.

Healthcare & Medical
01 Apr 2026
Award date
€1
Contract value

Buying agency

GWQ ServicePlus AG
207 Awards
€1 Avg award
Typical vs typical

Winning supplier

neuraxpharm Arzneimittel GmbH
5 Awards
3 Buyers
€2 Total won

Contract description

Germany – Pharmaceutical products – Bekanntmachung vergebener Aufträge nach §130 c SGB V zu dem Arzneimittel Ublituximab (Briumvi)

Premium

Related awards · GWQ ServicePlus AG

207 awards

The buyer's full award list ranked by value, with the winning supplier, date and sector on every row — plus CSV / API export.

Tender no.SupplierAmountDateSector

Full dataset

Unlock the full data.

Subscribe to reveal every row, year-over-year trends, and CSV / API export.

Unlock full dataset →

163 more awards from this buyer · full history & CSV export

Premium

Other wins · neuraxpharm Arzneimittel GmbH

5 wins

The supplier's complete win history across every buyer it sells to — not just the handful shown here.

Tender no.BuyerAmountDateSector
Locked rows — unlock the full dataset below.

Premium · full dataset

See the full award context.

Competing bids, award margins and every related contract for GWQ ServicePlus AG and neuraxpharm Arzneimittel GmbH — one subscription unlocks everything.

Sign Up Free →

Free account · cancel anytime · 14-day money-back

Sign Up